Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-4575

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-4575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 01)

Chemical structure of divalproex sodium. The diagram shows the molecular arrangement including sodium ions, carbon atoms, and hydrocarbon chains representing the compound's chemical formula.*

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)

A bar chart comparing percentages for two studies labeled Study 1 (YMRS) and Study 2 (YMRS). Each study includes two bars representing PBO and DVPX groups, showing approximately 26% and 60% for Study 1, and 29% and 58% for Study 2, respectively. Percentages are displayed on the vertical axis.*

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)

A cumulative percentage graph comparing % reduction in CPS rate between Divalproex Sodium and placebo across patient percentages. The graph shows % of patients on the x-axis from 100 to 0 and % reduction in CPS rate on the y-axis ranging from -100% to 100%, with indications for improvement, no change, and worsening.*

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)

A line plot depicting the percentage reduction in CPS rate among patients, with two curves representing high dose and low dose groups. The y-axis ranges from -100% to 100% indicating worsening to improvement, and the x-axis shows the percentage of patients. The graph compares patient response between high and low doses of the medication.*

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)

A bar chart comparing results between Placebo and Divalproex Sodium treatments across two studies. Study 1 shows higher values for Placebo than Divalproex Sodium, while Study 2 also shows higher values for Placebo compared to Divalproex Sodium. The chart visually contrasts the two treatments' outcomes within both studies.*

FDA Label Image

Remedy_label (Remedy Label)

Divalproex Sodium delayed release tablet label showing 500 mg strength, quantity of 30 tablets. NDC number 70518-4575-00 and packaging by RemedyRepack Inc. The label includes storage instructions and manufacturing details for BluePoint Labs, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.